Serum or plasma ferritin concentration as an index of iron deficiency and overload

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 7, 2015, Pages

  Garcia Casal, Maria N ^a   Pasricha, Sant Rayn ^b   Martinez, Ricardo X ^c   Lopez Perez, Lucero ^d   Peña Rosas, Juan Pablo ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c WHO   (Germany)

^d NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 GLYCOPROTEIN; C REACTIVE PROTEIN; FERRITIN; HEPCIDIN; PROTOPORPHYRIN ZINC;

ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; FERRITIN BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HUMAN; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON OVERLOAD; LIVER BIOPSY; LIVER FUNCTION TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEX DIFFERENCE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW;

EID: 85029926306     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011817     Document Type: Article

References (59)

1. Angelucci E, Brittenham GM, McLaren CE, Ripalti M, Baronciani D, Giardini C, et al. Hepatic iron concentration and total body iron stores in thalassemia major. New England Journal of Medicine 2000;343(5):327-31.
2. Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS, American Association for the Study of Liver Diseases. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011;54(1):328-43.
3. Baer DM, Simons JL, Staples RL, Rumore GJ, Morton CJ. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. American Journal of Medicine 1995;98(5):464.
4. Bain B, Bailey K. Pitfalls in obtaining and interpreting bone marrow aspirates: to err is human. Journal of Clinical Patholology 2011;64:373-9.
5. Barry M. Liver iron concentration, stainable iron, and total body storage iron. Gut 1974;15:411-5.
6. Beilby JP, Prins AW, Swanson NR. Determination of hepatic iron concentration in fresh and paraffin-embedded tissue. Clinical Chemistry 1999;45(4):573-4.
7. Beutler E, Robson MJ, Buttenwieser E. A comparison of the plasma iron, iron-binding capacity, sternal marrow iron and other methods in the clinical evaluation of iron stores. Annals of Internal Medicine 1958;48(1):60-82.
8. BloodSafe eLearning Australia. Iron deficiency anaemia. Available from http://bloodsafelearning.org.au/course/iron-deficiency-anaemia-ida/2011.
9. Bossuyt PM, Leeflang MM. Chapter 6: Developing Criteria for Including Studies. In:. Cochrane Handbook for Systematic Reviews of Diagnostic Test AccuracyVersion 0.4 [updated September 2008]. Available from http://srdta.cochrane.org/handbook-dta-reviews. The Cochrane Collaboration, 2008.
10. Brissot P, Le Lan C, Troadec MB, Ropert M, Gaboriau F, Lescoat G, et al. Diagnosis and treatment of HFE-haemochromatosis. In: Beaumont C, Béris P, Beuzard Y, Brugnara C editor(s). Disorders of erythropoiesis, erythrocytes and iron metabolism. European School of Haematology, 2009.
11. Bull-Henry K, Al-Kawas FH. Evaluation of occult gastrointestinal bleeding. American Family Physician 2013;87(6):430-6.
12. Camaschella C. Iron-deficiency anemia. New England Journal of Medicine 2015;372(19):1832-43.
13. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. Journal of Clinical Epidemiology 2005;58(9):882-93.
14. Ferraro S, Mozzi R, Panteghini M. Revaluating serum ferritin as a marker of body iron stores in the traceability era. Clinical Chemistry and Laboratory Medicine 2012;50(11):1911-6.
15. Ganz T. Systemic iron homeostasis. Physiological Reviews 2013;93(4):1721-41.
16. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490-7.
17. Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia: an overview. Journal of General Internal Medicine 1992;7(2):145-53.
18. Guyatt GH. Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6.
19. Hooper L, Ashton K, Harvey L, Decsi T, Fairweather-Tate S. Assessing potential biomarkers of micronutrient status by using a systematic review methodology: methods. American Journal of Clinical Nutrition 2009;89:1953S-1959S.
20. Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood 2014;123(5):615-24.
21. Li R, Chen X, Yan H, Deurenberg P, Garby L, Hautvast JG. Functional consequences of iron supplementation in iron-deficient female cotton mill workers in Beijing, China. American Journal of Clinical Nutrition 1994;59(4):908-13.
22. Liberati A, Altman D, TetzlaffJ, Mulrow C, Gøtzsche PC, Ioannidis J, et al. The PRISMA statement for reporting systematic and meta-analyses of studies that evaluate interventions: explanation and elaboration. PLoS Medicine 2009;6(7):1-28.
23. LozoffB. Iron deficiency and child development. Food and Nutrition Bulletin 2007;28(4 Suppl):S560-71.
24. Mei Z, Cogswell M, Parvanta I, Lynch S, Beard J, Stolzfus R, et al. Hemoglobin and ferritin are currently the most efficient Indicators of population response to iron interventions: an analysis of nine randomized controlled trials. Journal of Nutrition 2005;135:1974-80.
25. Malempati S, Joshi S, Lai S, Braner D, Tegtmeyer K. Bone marrow aspiration and biopsy. New England Journal of Medicine 2009;361:e28.
26. Netz DJ, Mascarenhas J, Stehling O, Pierik AJ, Lill R. Maturation of cytosolic and nuclear iron-sulfur proteins. Trends in Cell Biology 2014;24(5):303-12.
27. Ordway GA, Garry DJ. Myoglobin: an essential hemoprotein in striated muscle. Journal of Experimental Biology 2004;207(20):3441-6.
28. Papagiannakis P, Michalopoulos C, Papalexi F, Dalampoura D, Diamantidis MD. The role of Helicobacter pylori infection in hematological disorders. European Journal of Internal Medicine 2013;24(8):685-90.
29. Pasricha SR, Flecknoe-Brown SC, Allen KJ, Gibson PR, McMahon LP, Olynyk JK, et al. Diagnosis and management of iron deficiency anaemia: a clinical update. Medical Journal of Australia 2010;193(9):525-32.
30. Pasricha SR, Drakesmith H, Black J, Hipgrave D, Biggs BA. Control of iron deficiency anemia in low- and middle-income countries. Blood 2013;121(14):2607-17.
31. Pasricha SR, Low M, Thompson J, Farrell A, De-Regil LM. Iron supplementation benefits physical performance in women of reproductive age: a systematic review and meta-analysis. Journal of Nutrition 2014;144(6):906-14.
32. Peeling P, Dawson B, Goodman C, Landers G, Trinder D. Athletic induced iron deficiency: new insights into the role of inflammation, cytokines and hormones. European Journal of Applied Physiology 2008;103(4):381-91.
33. Phatak PD, Sham RL, Raubertas RF, Dunnigan K, O'Leary MT, Braggins C, et al. Prevalence of hereditary hemochromatosis in 16031 primary care patients. Annals of Internal Medicine 1998;129(11):954-61.
34. Piga A, Roggero S, Longo F, Ernst O, Rose C. Chapter 25: Evaluation and treatment of secondary iron overload. In: Beaumont C, Béris P, Beuzard Y, Brugnara C editor(s). Disorders of erythrocytes, erythropoiesis and iron metabolism. European School of Haematology, 2009.
35. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology 2005;58(10):982-90.
36. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
37. Riley R, Williams D, Ross M, Zhao S, Chesney A, Clark B, et al. Bone marrow aspirate and biopsy II. Interpretation of the bone marrow aspirate and biopsy. Journal of Clinical Laboratory Analysis 2009;23:259-309.
38. SAS Institute Inc. SAS software. version 9.4. Cary: SAS Institute Inc, 2015.
39. Singh S, Chang SM, Matchar DB, Bass EB. Chapter 7: Grading a body of evidence on diagnostic tests. Journal of General Internal Medicine 2012;27(Suppl 1):47-55.
40. Spencer B. Blood donor iron status: are we bleeding them dry?. Current Opinion in Hematology 2013;20(6):533-9.
41. St Pierre T, Clark P, Chua-Anusorn W. Measurement and mapping of liver iron concentrations using magnetic resonance imaging. Annals of the New York Academy of Sciences 2005;1054:379-85.
42. St Pierre TG, Clark PR, Chua-anusorn W, Fleming AJ, Jeffrey GP, Olynyk JK, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 105;2:855-61.
43. St Pierre TG, El-Beshlawy A, Elalfy M, Al Jefri A, Al Zir K, Daar S, et al. Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration. Magnetic Resonance in Medicine 2014;71(6):2215-23.
44. Stevens GA, Finucane MM, De-Regil LM, Paciorek CJ, Flaxman SR, Branca F, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Global Health 2013;1(1):e16-25.
45. Takwoingi Y, Deeks J. MetaDAS: A SAS macro for meta-analysis of diagnostic accuracy studies. Quick reference and worked example. Version 1.3. 2010 July. Available from: http://srdta.cochrane.org/.
46. Verdon F, Burnand B, Stubi CL, Bonard C, GraffM, Michaud A, et al. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ 2003;326(7399):1124.
47. Weatherall DJ. The inherited disorders of haemoglobin: an increasingly neglected global health burden. Indian Journal of Medical Research 2011;134(4):493-7.
48. Whiting P, Rutjes AWS, Reitsma JB, Bossuyt P, Keijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Medical Research Methodology 2003;3:25-38.
49. Whiting PF, Weswood ME, Rutjes AWS, Reitsma JB, Bossuyt PNM, Kleijnen J. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Medical Research Methodology 2006;6:9-17.
50. Whiting PF, Rutjes AW, WestwoodME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155(8):529-36.
51. World Health Organization. Preventing and controlling anaemia through primary health care: a guide for health administrators and programme managers. Available from http://www.who.int/nutrition/publications/micronutrients/anaemia_iron_deficiency/9241542497.pdf. Vol. (ISBN: 92 4 154249 7), Geneva: World Health Organization, 1989.
52. World Health Organization. Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers. Geneva, World Health Organization, 2001 (WHO/NHD/01.3); Available from http://apps.who.int/iris/bitstream/10665/66914/1/WHO_NHD_01.3.pdf?ua=1. Geneva: World Health Organization, 2001.
53. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organization, 2011 (WHO/NMH/NHD/MNM/11.1). Available from http://apps.who.int/iris/bitstream/10665/85839/3/WHO_NMH_NHD_MNM_11.1_eng.pdf?ua=1.
54. World Health Organization. Serum ferritin concentrations for the assessment of iron status and iron deficiency in populations. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organization, 2011 (WHO/NMH/NHD/MNM/11.2. Available from http://www.who.int/vmnis/indicators/serum_ferritin.pdf=.
55. World Health Organization/Centers for Disease Control and Prevention. Assessing the iron status of populations: including literature reviews. Report of a Joint World Health Organization/Centers for Disease Control and Prevention Technical Consultation on the Assessment of Iron Status at the Population Level, Geneva, Switzerland, 6-8 April 2004. Available from http://www.who.int/nutrition/publications/micronutrients/anaemia_iron_deficiency/9789241596107.pdf. 2nd Edition. Geneva: World Health Organization, 2007.
56. Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005;106(4):1460-5.
57. Wood J. Diagnosis and management of transfusion iron overload: The role of imaging. American Journal of Hematology 2007;82:1132-5.
58. Wood J. Magnetic resonance imaging measurement of iron overload. Current Opinion in Hematology 2007;4(3):183-90.
59. Wood JC. Impact of iron assessment by MRI. Hematology, the ASH Education Program 2011;2011(1):443-50.